
Progress in Drug Research
Birkhäuser (Publisher)
Published on 16. October 2012
Book
Paperback/Softback
VII, 286 pages
978-3-0348-9749-5 (ISBN)
Description
Hypertension is one of the cardiovascular diseases which is most common throughout the world. It is generally defined as an elevation of systolic and/or diastolic arterial blood pressure, which is 120/80 mm Hg in normal situation. A value of 140/90 mm is generally accepted as the upper limit of normotension. Hypertension with certain risk factors such as hypercholes terolemia, diabetes, smoking and a family history of vascular disease pre disposes to arteriosclerosis and consequent cardiovascular morbidity and mortality. The treatment of hypertension leads to reduced risk of hyperten sive renal failure, haemorrhagic stroke, myocardial infarction and cardiac failure. In most cases, the cause of the hypertension can not be clearly defined. Such hypertension is termed as essential hypertension. In a few cases (5- 15%), the hypertension is secondary to definable causes, such as renal artery stenosis, a pheochromocytoma, or an endocrine disorder. This type of hyper tension is known as secondary hypertenSion. Although the exact etiology of essential hypertension is still not well known, the following factors are sup posed to play causative roles.
More details
Series
Edition
Softcover reprint of the original 1st ed. 1999
Language
English
Place of publication
Basel
Switzerland
Publishing group
Springer Basel
Target group
Professional and scholarly
Research
Illustrations
VII, 286 p.
Dimensions
Height: 244 mm
Width: 170 mm
Thickness: 17 mm
Weight
522 gr
ISBN-13
978-3-0348-9749-5 (9783034897495)
DOI
10.1007/978-3-0348-8735-9
Schweitzer Classification
Other editions
Additional editions

Book
10/1999
1st Edition
Springer
€85.55
Article exhausted; check different version
Persons
Content
U-50,488 and the K receptor. Part II: 1991-1998.- Quantitative structure-activity relationships of antihypertensive agents.- Combinatorial chemistry: Polymer supported synthesis of peptide and nonpeptide libraries.- From genome to drug - optimising the drug discovery process.- Phosphodiesterase 4 (PDE4) inhibitors in asthma and chronic obstructive pulmonary disease (COPD.- Index Vol. 53.- Index of titles, Vol. 1-53.- Author and paper index, Vol. 1-53.